Water Injection, Powder, Lyophilized, For Solution
NDC Package 84502-106-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Water injection is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Fujian Genohope Biotech Ltd., this product is identified by NDC 84502-106.

Identification & Billing

NDC Package Code
84502-106-01
Package Description
1 mL in 1 SYRINGE, GLASS
Product Code
84502-106
11-Digit Billing Format
84502010601

Clinical Specifications

Proprietary Name
Water
Non-Proprietary Name
Water
Substance Name
Water
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Active Ingredient(s)
WATER 1 mL/mL

Regulatory & Marketing

Labeler Name
Fujian Genohope Biotech Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
05-06-2025
End Marketing Date
06-30-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84502-106-01 identifies a specific commercial package of 1 ml in 1 syringe, glass of Water (UNFINISHED drug), a bulk ingredient labeled by Fujian Genohope Biotech Ltd.. This injection, powder, lyophilized, for solution is formulated for use and contains water as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fujian Genohope Biotech Ltd. on May 06, 2025.

How is this Fujian Genohope Biotech Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84502010601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84502-106-01
11-Digit CMS (5-4-2)
84502-0106-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.